SLC6A14 and posterior cortical atrophy: Taken together, the results presented herein suggest that alloferon might be a useful adjuvant for gemcitabine-based chemotherapy for PCa, particularly PCa that expresses high levels of SLC6A14 and is highly resistant to gemcitabine.